Chevron Stock Soars Amid Surge in Global Oil Prices
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2 hours ago
0mins
Should l Buy CVX?
Source: Fool
- Oil Price Surge: The war with Iran caused Brent crude prices to skyrocket by 43% in March, closing at nearly $104 per barrel, marking the largest monthly gain since 2020, which directly contributed to Chevron's 10.8% stock increase.
- Earnings Outlook Boost: Every $1 increase in Brent oil price translates to an additional $600 million in annualized earnings for Chevron, making the prospect of higher earnings a significant driver for the stock's surge, highlighting the company's profitability in a high oil price environment.
- Venezuela Production Deal: Chevron is nearing a deal with Venezuela to secure production rights in the Ayacucho 8 area, which would significantly enhance its output in the country and further strengthen its growth prospects.
- Collaboration with Microsoft: Chevron and Engine No. 1 have entered into an exclusive agreement to develop a 2.5-gigawatt gas-fired power plant in partnership with Microsoft, with an estimated cost of $7 billion, which will utilize Chevron's natural gas production for power generation, thereby reducing overall earnings volatility.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CVX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CVX
Wall Street analysts forecast CVX stock price to fall
19 Analyst Rating
15 Buy
4 Hold
0 Sell
Strong Buy
Current: 198.970
Low
158.00
Averages
176.95
High
206.00
Current: 198.970
Low
158.00
Averages
176.95
High
206.00
About CVX
Chevron Corporation is an integrated energy company. The Company produces crude oil and natural gas; manufactures transportation fuels, lubricants, petrochemicals and additives; and develops technologies that enhance its business and industry. The Company’s segments include Upstream and Downstream. Upstream operations consist primarily of exploring for, developing, producing and transporting crude oil and natural gas; liquefaction, transportation and regasification associated with LNG; transporting crude oil by major international oil export pipelines; processing, transporting, storage and marketing of natural gas; carbon capture and storage; and a gas-to-liquids plant. Downstream operations consist primarily of the refining of crude oil into petroleum products; marketing crude oil, refined products, and lubricants; manufacturing and marketing of renewable fuels, and transporting of crude oil and refined products by pipeline, marine vessel, motor equipment and rail car.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- AI Chip Supply Agreement: Broadcom has entered into an agreement to supply AI chips to Google and signed an expanded deal with Anthropic to provide approximately 3.5 gigawatts of computing capacity, which is expected to significantly enhance Google's competitive edge in the AI sector.
- Stock Price Reaction: Broadcom shares rose by 3%, while Alphabet's shares increased slightly by 0.2%, reflecting the market's positive outlook on the collaboration and its potential to drive future technological innovations and market share growth.
- S&P 500 Component Change: Casey's General Stores will replace Hologic in the S&P 500 prior to Thursday's open, with Casey's shares rising about 1%, while Hologic's shares were halted due to the completion of its acquisition by Blackstone and TPG Global, indicating increased market confidence in Casey's.
- Medicare Payment Increase: Healthcare stocks surged as the Center for Medicare & Medicaid Services finalized a payment increase for privately run Medicare Advantage plans, with Humana's shares soaring nearly 10%, UnitedHealth rising 6%, and CVS Health advancing nearly 7%, signaling optimistic sentiment towards the healthcare insurance sector.
See More
- Oil Price Surge: The war with Iran caused Brent crude prices to skyrocket by 43% in March, closing at nearly $104 per barrel, marking the largest monthly gain since 2020, which directly contributed to Chevron's 10.8% stock increase.
- Earnings Outlook Boost: Every $1 increase in Brent oil price translates to an additional $600 million in annualized earnings for Chevron, making the prospect of higher earnings a significant driver for the stock's surge, highlighting the company's profitability in a high oil price environment.
- Venezuela Production Deal: Chevron is nearing a deal with Venezuela to secure production rights in the Ayacucho 8 area, which would significantly enhance its output in the country and further strengthen its growth prospects.
- Collaboration with Microsoft: Chevron and Engine No. 1 have entered into an exclusive agreement to develop a 2.5-gigawatt gas-fired power plant in partnership with Microsoft, with an estimated cost of $7 billion, which will utilize Chevron's natural gas production for power generation, thereby reducing overall earnings volatility.
See More
- Oil Price Surge: The war with Iran has caused Brent crude prices to soar by 43% in March, closing at nearly $104 per barrel, marking the largest monthly gain since 2020, which will significantly boost Chevron's earnings, with every $1 increase translating to an additional $600 million in annual profits.
- Venezuela Production Deal: Chevron is nearing an agreement with Venezuela to secure production rights in the Ayacucho 8 area, which holds substantial reserves, expected to significantly enhance Chevron's output in the country and further strengthen its growth prospects.
- Exclusive Partnership with Microsoft: Chevron and investment firm Engine No. 1 have entered into an exclusive agreement to build a 2.5 gigawatt gas-fired power plant to support a large data center, with an estimated cost of $7 billion and a potential startup next year, allowing Chevron to utilize its produced natural gas for power generation, thereby reducing overall earnings volatility.
- Strong Stock Performance: Chevron's stock has rallied over 30% this year, significantly outperforming the S&P 500's roughly 4% decline, although the market anticipates a potential end to the conflict, which could lead to a drop in oil prices; however, if tensions escalate, Chevron's stock could see substantial upside.
See More
- Chevron's Export Activity: Chevron continues to export ten million barrels of crude oil without interruption.
- Market Impact: The ongoing export of crude oil by Chevron may influence global oil prices and supply dynamics.
See More
- Pessimistic Global Outlook: IMF Managing Director Kristalina Georgieva warned in Davos that the Iran war will lead to higher inflation and slower growth, with global growth forecasts for 2026 expected to be downgraded from 3.3%.
- Energy Supply Shock: The effective closure of the Strait of Hormuz has resulted in a 13% reduction in global oil supply, causing significant disruptions in energy supply; although shipping is gradually resuming, it remains far below pre-war levels, impacting global economic recovery.
- Severe Impact on Poor Nations: Georgieva cautioned that the poorest countries lacking sufficient reserves will be the most affected, highlighting increasing global economic inequality that could lead to social unrest and instability.
- Rising Stagflation Risks: The dual threat of high inflation and slower economic growth is intensifying concerns about
See More
- United Therapeutics Performance: With a remarkable 16.9% annual revenue growth over the past two years, United Therapeutics has expanded its market share in pulmonary hypertension treatments, while a strong free cash flow margin of 34.2% allows for consistent reinvestment or capital return, enhancing profitability and investment opportunities.
- Coastal Financial Growth: The company has achieved an impressive 40.1% annual net interest income growth over the last five years, indicating significant market share gains, with a strong loan book performance reflected in a best-in-class net interest margin of 7.1%, and an annual EPS growth of 19.6%, far surpassing its peers.
- Chevron's Steady Revenue: Chevron's annual revenue growth of 14.8% over the past five years exceeds the sector average, supported by a massive revenue base of $189 billion that solidifies its market influence, while an 11% free cash flow margin provides flexibility for reinvestment or shareholder returns, further strengthening its market position.
- Market Trend Analysis: These companies exhibit strong revenue growth potential, with five-year returns of 192%, 199%, and 90.7% for United Therapeutics, Coastal Financial, and Chevron respectively, highlighting their competitiveness and future growth prospects in their respective sectors.
See More










